ZA201701851B - Fmdv recombinant vaccines and uses thereof - Google Patents
Fmdv recombinant vaccines and uses thereofInfo
- Publication number
- ZA201701851B ZA201701851B ZA2017/01851A ZA201701851A ZA201701851B ZA 201701851 B ZA201701851 B ZA 201701851B ZA 2017/01851 A ZA2017/01851 A ZA 2017/01851A ZA 201701851 A ZA201701851 A ZA 201701851A ZA 201701851 B ZA201701851 B ZA 201701851B
- Authority
- ZA
- South Africa
- Prior art keywords
- recombinant vaccines
- fmdv recombinant
- fmdv
- vaccines
- recombinant
- Prior art date
Links
- 108010008038 Synthetic Vaccines Proteins 0.000 title 1
- 229940124551 recombinant vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/135—Foot- and mouth-disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10041—Use of virus, viral particle or viral elements as a vector
- C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14041—Use of virus, viral particle or viral elements as a vector
- C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462054073P | 2014-09-23 | 2014-09-23 | |
| PCT/US2015/051755 WO2016049209A1 (en) | 2014-09-23 | 2015-09-23 | Fmdv recombinant vaccines and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201701851B true ZA201701851B (en) | 2018-05-30 |
Family
ID=54256845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2017/01851A ZA201701851B (en) | 2014-09-23 | 2017-03-15 | Fmdv recombinant vaccines and uses thereof |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10010605B2 (enExample) |
| EP (1) | EP3197486A1 (enExample) |
| JP (1) | JP6931327B2 (enExample) |
| KR (1) | KR102526219B1 (enExample) |
| CN (1) | CN107073100B (enExample) |
| AP (1) | AP2017009834A0 (enExample) |
| AR (1) | AR102006A1 (enExample) |
| AU (2) | AU2015320673B2 (enExample) |
| CA (1) | CA2962225A1 (enExample) |
| JO (1) | JO3600B1 (enExample) |
| MA (1) | MA40151B2 (enExample) |
| MX (1) | MX388708B (enExample) |
| RU (1) | RU2745373C2 (enExample) |
| TW (1) | TWI733653B (enExample) |
| WO (1) | WO2016049209A1 (enExample) |
| ZA (1) | ZA201701851B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108367066B (zh) * | 2015-09-10 | 2023-08-11 | 台湾地区“中央研究院” | 包括类病毒颗粒及新型佐剂的禽流感疫苗组合物 |
| AU2016361305B2 (en) | 2015-11-23 | 2020-02-06 | Boehringer Ingelheim Animal Health USA Inc. | FMDV and E2 fusion proteins and uses thereof |
| TWI760322B (zh) | 2016-01-29 | 2022-04-11 | 美商百靈佳殷格翰動物保健美國有限公司 | 重組腺病毒載體裝載之fmdv疫苗及其用途 |
| US10172933B2 (en) * | 2016-10-31 | 2019-01-08 | The United States Of America, As Represented By The Secretary Of Agriculture | Mosaic vaccines for serotype a foot-and-mouth disease virus |
| WO2019014144A1 (en) * | 2017-07-12 | 2019-01-17 | Boehringer Ingelheim Vetmedica, Inc. | IMMUNOGENIC COMPOSITIONS BASED ON SENECAVIRUS TYPE A AND CORRESPONDING METHODS |
| CN108103034B (zh) * | 2017-12-15 | 2022-06-24 | 云南农业大学动物医学院 | 同时表达A型、O型和Asia-1型口蹄疫病毒VP1基因重组腺病毒、构建方法及应用 |
| CN108530522B (zh) * | 2018-03-14 | 2021-09-17 | 中华人民共和国汕头海关 | 一种重组的OmpK多表位多肽、构建方法及其应用 |
| CN110467654B (zh) * | 2018-05-11 | 2022-08-09 | 普莱柯生物工程股份有限公司 | 口蹄疫病毒样颗粒抗原、其制备的疫苗组合物及其制备方法和应用 |
| CN111233984B (zh) * | 2018-11-29 | 2022-08-12 | 普莱柯生物工程股份有限公司 | 一种o型口蹄疫病毒样颗粒抗原、及其疫苗组合物、制备方法和应用 |
| US12226472B2 (en) * | 2019-01-15 | 2025-02-18 | Pulike Biological Engineering, Inc. | Foot-and-mouth disease virus-like particle antigen, and vaccine composition, preparation method, and application thereof |
| WO2020263062A1 (ko) * | 2019-06-28 | 2020-12-30 | (주)플럼라인생명과학 | 구제역 바이러스 백신 조성물 |
| WO2022084438A1 (en) * | 2020-10-22 | 2022-04-28 | Intervet International B.V. | Baculovirus expression vector |
| JP2023549460A (ja) * | 2020-10-22 | 2023-11-27 | インターベット インターナショナル ベー． フェー． | バキュロウイルス発現ベクター |
| US12453767B2 (en) * | 2021-08-18 | 2025-10-28 | The United States Of America, As Represented By The Secretary Of Agriculture | Development of mosaic vaccines against foot and mouth disease virus serotype O |
| WO2023021168A1 (en) * | 2021-08-20 | 2023-02-23 | Intervet International B.V. | Method of producing a foot and mouth disease virus virus-like particle |
| CN117836000A (zh) * | 2021-08-20 | 2024-04-05 | 英特维特国际股份有限公司 | 产生口蹄疫病毒病毒样颗粒的方法 |
| EP4387665A1 (en) * | 2021-08-20 | 2024-06-26 | The Pirbright Institute | Fmdv virus-like particle with double stabilizing mutation |
| IL310908A (en) * | 2021-08-20 | 2024-04-01 | Intervet Int Bv | A virus-like FMDV particle with a stabilizing mutation |
| KR102513632B1 (ko) * | 2021-11-30 | 2023-03-28 | 주식회사 왓슨알앤디 | 구제역 바이러스 유사 입자를 생산하기 위한 백신 플랫폼 |
| US12036318B2 (en) * | 2022-02-16 | 2024-07-16 | Chemical & Schutz High Performance Lubricants, S.A. De C.V. | Self-emulsionable mineral oil as a vehicle in vaccines for poultry |
| EP4628096A1 (en) | 2022-11-23 | 2025-10-08 | Optipharm Co., Ltd. | Recombinant expression vector for preparing foot-and-mouth disease virus-like particles or nanoparticles, and vaccine composition using same |
| JP2025538585A (ja) * | 2022-11-23 | 2025-11-28 | オプティファーム カンパニー リミテッド | 口蹄疫ウィルス様粒子またはナノ粒子生産のための組換え発現ベクターおよびこれを用いたワクチン組成物 |
| CN117210501B (zh) * | 2023-09-13 | 2024-06-07 | 中国农业科学院兰州兽医研究所 | 口蹄疫病毒2b蛋白免疫抑制位点突变的重组口蹄疫病毒株的构建 |
| CN117304277B (zh) * | 2023-09-26 | 2024-03-08 | 中国农业科学院兰州兽医研究所 | 一种o型口蹄疫病毒vp4蛋白t细胞表位多肽及其应用 |
| US20250134984A1 (en) * | 2023-10-26 | 2025-05-01 | The United States Of America, As Represented By The Secretary Of Agriculture | Development of mosaic vaccines against foot and mouth disease virus serotype asia |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA915593B (en) | 1990-07-24 | 1993-03-31 | Novagene Inc | Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same |
| FR2810888B1 (fr) * | 2000-06-29 | 2004-07-30 | Merial Sas | Vaccin contre la fievre aphteuse |
| CA2571560C (en) * | 2004-06-25 | 2016-04-12 | Merial Limited | Avipox recombinants expressing foot and mouth disease virus genes |
| EP1951297A2 (en) | 2005-11-10 | 2008-08-06 | GenVec, Inc. | Adenoviral vector-based foot-and-mouth disease vaccine |
| BRPI0906946A2 (pt) * | 2008-01-09 | 2015-07-14 | Univ Konkuk Ind Coop Corp | Vacinas baseadas em baculovírus |
| CN101270155B (zh) * | 2008-05-06 | 2011-04-27 | 中国农业科学院兰州兽医研究所 | 通过耐酸性改造在昆虫中组装口蹄疫病毒空衣壳的方法 |
| GB0810710D0 (en) * | 2008-06-11 | 2008-07-16 | Animal Health Inst | Vaccine |
| NZ702145A (en) * | 2010-03-12 | 2016-03-31 | Merial Inc | Bluetongue virus recombinant vaccines and uses thereof |
| PT2707385T (pt) * | 2011-05-13 | 2017-12-19 | Glaxosmithkline Biologicals Sa | Antigénios de f de rsv pré-fusão |
| GB201111183D0 (en) * | 2011-06-30 | 2011-08-17 | Animal Health Inst | Peptide |
| CA2876762A1 (en) * | 2012-06-18 | 2013-12-27 | Novartis Ag | Stabilized gp120 |
| US9738689B2 (en) * | 2013-03-13 | 2017-08-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Prefusion RSV F proteins and their use |
-
2015
- 2015-09-23 MX MX2017003712A patent/MX388708B/es unknown
- 2015-09-23 TW TW104131548A patent/TWI733653B/zh active
- 2015-09-23 KR KR1020177010941A patent/KR102526219B1/ko active Active
- 2015-09-23 RU RU2017113571A patent/RU2745373C2/ru active
- 2015-09-23 WO PCT/US2015/051755 patent/WO2016049209A1/en not_active Ceased
- 2015-09-23 AP AP2017009834A patent/AP2017009834A0/en unknown
- 2015-09-23 AR ARP150103061A patent/AR102006A1/es active IP Right Grant
- 2015-09-23 CA CA2962225A patent/CA2962225A1/en active Pending
- 2015-09-23 AU AU2015320673A patent/AU2015320673B2/en active Active
- 2015-09-23 JP JP2017516077A patent/JP6931327B2/ja active Active
- 2015-09-23 CN CN201580057248.4A patent/CN107073100B/zh active Active
- 2015-09-23 MA MA40151A patent/MA40151B2/fr unknown
- 2015-09-23 US US14/863,181 patent/US10010605B2/en active Active
- 2015-09-23 EP EP15775553.9A patent/EP3197486A1/en active Pending
- 2015-09-28 JO JOP/2015/0240A patent/JO3600B1/ar active
-
2017
- 2017-03-15 ZA ZA2017/01851A patent/ZA201701851B/en unknown
-
2019
- 2019-07-30 AU AU2019210537A patent/AU2019210537A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015320673B2 (en) | 2019-05-02 |
| JP6931327B2 (ja) | 2021-09-01 |
| MX388708B (es) | 2025-03-20 |
| MX2017003712A (es) | 2017-06-28 |
| BR112017005833A8 (pt) | 2023-02-14 |
| AP2017009834A0 (en) | 2017-03-31 |
| AU2019210537A1 (en) | 2019-08-15 |
| TW201625297A (zh) | 2016-07-16 |
| TWI733653B (zh) | 2021-07-21 |
| CN107073100B (zh) | 2021-02-26 |
| MA40151A1 (fr) | 2018-01-31 |
| KR102526219B1 (ko) | 2023-04-26 |
| RU2745373C2 (ru) | 2021-03-24 |
| US10010605B2 (en) | 2018-07-03 |
| KR20170058430A (ko) | 2017-05-26 |
| JP2017530124A (ja) | 2017-10-12 |
| RU2017113571A (ru) | 2018-10-26 |
| AU2015320673A1 (en) | 2017-05-11 |
| BR112017005833A2 (pt) | 2018-02-27 |
| CA2962225A1 (en) | 2016-03-31 |
| CN107073100A (zh) | 2017-08-18 |
| AR102006A1 (es) | 2017-01-25 |
| WO2016049209A1 (en) | 2016-03-31 |
| JO3600B1 (ar) | 2020-07-05 |
| RU2017113571A3 (enExample) | 2019-04-22 |
| EP3197486A1 (en) | 2017-08-02 |
| US20160220659A1 (en) | 2016-08-04 |
| MA40151B2 (fr) | 2022-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201701851B (en) | Fmdv recombinant vaccines and uses thereof | |
| ZA201804071B (en) | Recombinant zika vaccines | |
| IL286265A (en) | A new tilapia virus and its uses | |
| ZA201700165B (en) | Influenza virus vaccines and uses thereof | |
| IL247014A0 (en) | 6-heteroaryloxy and 6-aryloxy-quinoline-2-carboxamides and their use | |
| PL3152226T3 (pl) | Modyfikowane cyklopentapeptydy i ich zastosowania | |
| SG11201610443WA (en) | Influenza virus vaccines and uses thereof | |
| ZA201801172B (en) | Mycoplasma vaccines and uses thereof | |
| HUE049826T2 (hu) | Legyengített szarvasmarha koronavírus és az ezzel összefüggõ vakcinák | |
| ZA201704105B (en) | Refractories and use thereof | |
| IL247159B (en) | Components of pcsk9 | |
| IL247185B (en) | Tilapia virus vaccines | |
| IL287985A (en) | A peptide derived from koc1 and a component containing it | |
| IL258056A (en) | Foxm1-derived peptide and a component containing it | |
| GB201608821D0 (en) | Vaccines | |
| GB201402352D0 (en) | Vaccines, polypeptides, and nucleic acids | |
| SG11201708247XA (en) | A vaccine composition and uses thereof | |
| IL250235A0 (en) | A peptide derived from urlc10 and a component containing it | |
| IL250215A0 (en) | A peptide derived from cdca1 and a component containing it | |
| SG11201610918RA (en) | Peptides and uses thereof | |
| IL258107A (en) | Peptide derivative - mphosph1 and a component containing it | |
| IL249704A0 (en) | Influenza virus vaccines and their uses | |
| IL249705A0 (en) | Influenza virus vaccines and their uses | |
| HK1257010A1 (en) | Fcv recombinant vaccines and uses thereof | |
| AU2014902031A0 (en) | Immunogenic vaccines and uses thereof |